A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Citadel Advisors LLC holds 2,275,700 shares of XBI stock, worth $209 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
2,275,700
Previous 3,523,900 35.42%
Holding current value
$209 Million
Previous $327 Million 31.18%
% of portfolio
0.04%
Previous 0.07%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$90.87 - $102.43 $45.9 Million - $51.7 Million
505,076 Added 742.79%
573,073 $56.6 Million
Q2 2024

Aug 14, 2024

SELL
$82.22 - $94.12 $153 Million - $175 Million
-1,858,484 Reduced 96.47%
67,997 $6.3 Million
Q1 2024

May 15, 2024

BUY
$87.05 - $102.89 $104 Million - $123 Million
1,193,749 Added 162.92%
1,926,481 $183 Million
Q4 2023

Feb 14, 2024

SELL
$64.12 - $90.86 $55.2 Million - $78.2 Million
-860,793 Reduced 54.02%
732,732 $65.4 Million
Q3 2023

Nov 14, 2023

BUY
$71.88 - $85.76 $89.9 Million - $107 Million
1,251,157 Added 365.44%
1,593,525 $116 Million
Q2 2023

Aug 14, 2023

BUY
$75.38 - $90.23 $22.9 Million - $27.4 Million
303,365 Added 777.8%
342,368 $28.5 Million
Q1 2023

May 15, 2023

SELL
$73.13 - $91.97 $27.5 Million - $34.6 Million
-375,720 Reduced 90.6%
39,003 $2.97 Million
Q4 2022

Feb 14, 2023

SELL
$76.72 - $85.66 $4.87 Million - $5.44 Million
-63,538 Reduced 13.29%
414,723 $34.4 Million
Q3 2022

Nov 14, 2022

BUY
$75.06 - $94.9 $27.3 Million - $34.6 Million
364,210 Added 319.34%
478,261 $37.9 Million
Q2 2022

Aug 15, 2022

SELL
$62.81 - $96.09 $13.6 Million - $20.7 Million
-215,811 Reduced 65.42%
114,051 $8.47 Million
Q1 2022

May 16, 2022

BUY
$81.07 - $115.44 $18.4 Million - $26.2 Million
226,639 Added 219.56%
329,862 $29.6 Million
Q4 2021

Feb 14, 2022

SELL
$108.77 - $134.15 $6.12 Million - $7.55 Million
-56,295 Reduced 35.29%
103,223 $0
Q3 2021

Nov 15, 2021

BUY
$118.69 - $138.49 $15 Million - $17.5 Million
126,522 Added 383.45%
159,518 $20.1 Million
Q2 2021

Aug 16, 2021

SELL
$122.48 - $139.69 $2.68 Million - $3.06 Million
-21,896 Reduced 39.89%
32,996 $0
Q4 2020

Feb 16, 2021

SELL
$110.36 - $151.14 $310,332 - $425,005
-2,812 Reduced 4.87%
54,892 $7.73 Million
Q3 2020

Nov 16, 2020

SELL
$103.87 - $120.36 $17.8 Million - $20.7 Million
-171,694 Reduced 74.85%
57,704 $6.43 Million
Q2 2020

Aug 14, 2020

BUY
$73.26 - $114.17 $11.3 Million - $17.6 Million
154,533 Added 206.42%
229,398 $25.7 Million
Q1 2020

May 15, 2020

SELL
$65.95 - $98.35 $2.3 Million - $3.43 Million
-34,917 Reduced 31.81%
74,865 $5.8 Million
Q2 2019

Aug 14, 2019

BUY
N/A
73,078 Added 199.1%
109,782 $9.63 Million
Q1 2019

May 15, 2019

BUY
N/A
2,609 Added 7.65%
36,704 $0
Q4 2018

Feb 14, 2019

BUY
N/A
13,428 Added 64.97%
34,095 $0
Q3 2018

Nov 13, 2018

SELL
N/A
-274,761 Reduced 93.0%
20,667 $0
Q2 2018

Aug 10, 2018

BUY
N/A
171,544 Added 138.47%
295,428 $0
Q1 2018

May 11, 2018

BUY
N/A
110,404 Added 819.02%
123,884 $10.9 Million
Q4 2017

Feb 09, 2018

SELL
N/A
-273,519 Reduced 95.3%
13,480 $1.14 Million
Q3 2017

Nov 09, 2017

BUY
N/A
286,999
286,999 $24.8 Million

Others Institutions Holding XBI

About SPDR SER TR SPDR S&P BIOTECH E


  • Ticker XBI
  • Sector ETFs
  • Industry ETFs
More about XBI
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.